MS patients who are using oral MS medications tend to be younger than patients using other treatment options such as injections. Not surprisingly, patients on injectables and other options have been taking their treatment for a longer period of time than patients on oral MS medications.
Note: The MS in America study was solely funded by Health Union, LLC the publisher of MultipleSclerosis.net. The primary goal of the study was to establish an understanding of the current state and trends of patients affected by Multiple Sclerosis. Health Union, LLC does not manufacture, sell nor market any product to diagnose, prevent, or treat MS or any other disease, but is the creator and publisher of in-depth, condition-specific online communities. Health Union’s communities are always free to users and are supported by transparent advertising and sponsorships.
Written by: Jonathan Simmons | Last reviewed: May 2015.